Beta-sitosterol is a phytosterol, which could mediate the p53/NF-κB/BCRP signaling pathway to alleviate multidrug resistance in the treatment of CRC and, combined with oxaliplatin, could be a potential way to improve CRC therapy efficacy (22). This evidence concerns the gene ABCG2 and colorectal carcinoma.